Histidine Hydrochloride Anhydrous
ExcipientCAS 645-35-2UNII 1D5Q932XM6
1 organisation holds 1 active FDA Type IV Drug Master File for Histidine Hydrochloride Anhydrous.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology
Active Type IV DMFs (1)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| HUBEI GEDIAN HUMANWELL PHARMACEUTICAL EXCIPIENTS CO LTD China | 41567 | HISTIDINE HYDROCHLORIDE | Jun 2025 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Histidine Hydrochloride Anhydrous.
For suppliers
Do you supply Histidine Hydrochloride Anhydrous?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.